中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/2375
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1511917      Online Users : 409
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > China Medical University Hospital > Jurnal articles >  Item 310903500/2375
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/2375


    Title: Chronic Hepatitis C Infection Is Associated with Higher Hemoglobin Levels in Hemodialysis Patients, But Hepatitis B Infection Is Not
    Authors: 陳志濱(Chih-Bin Chen);周哲毅(Che-Yi Chou)*;曾裕雄(Yu-Hsiung Tseng);黃秋錦(Chiu-Ching Huang);陳偉德(Walter Chen);施純明(Chuen-Ming Shih)
    Contributors: 中國附醫內科部消化系
    Date: 2008-01
    Issue Date: 2009-08-20 17:30:22 (UTC+8)
    Abstract: BACKGROUND
    Chronic hepatitis is associated with increased hemoglobin level in patients with end-stage renal disease. The aim of this study was to define the individual and combined influence of chronic hepatitis B and C infections on red blood cell status.

    METHODS
    A total of 524 chronic hemodialysis patients at 5 hemodialysis centers were retrospectively reviewed for the period from March 1 to June 31, 2005. The results of testing using a third-generation enzyme-linked immunosorbent assay showed that 345 patients (65.8%) had neither HBV nor HCV (NBC), 55 patients (10.5%) had HBV, 108 (20.6%) had HCV, and 16 (3.1%) had concurrent HBV and HCV infection (BBC). Differences between the 4 groups of patients in the parameters studied were investigated using a multivariate general linear model with the Sidak post hoc test.

    RESULTS
    The hemoglobin and hematocrit of patients with HCV were 10.5 ± 1.6 g/dL and 31.6% ± 4.7%, respectively, which were significantly higher than the 9.9 ± 1.4 g/dL and 29.7% ± 4% of NBC patients (p = 0.002 and p = 0.001). The erythropoietin (EPO) dose given to patients with HCV was 39.3 ± 40.3 IU/kg/week, significantly lower than the 58.1 ± 40.6 IU/kg/week for those with NBC. The results of the multivariate linear regression analysis suggested that erythropoietin dose, elevated liver functional test results, and HCV infection were major factors affecting red cell production (p < 0.001, p < 0.02, and p < 0.05, respectively).

    CONCLUSION
    Hepatitis C virus infection was associated with an increased number of red blood cells, which led to a lowering of the necessary EPO dose, whereas hepatitis B virus infection was not.
    Relation: DIALYSIS & TRANSPLANTATION37(1):12~17
    Appears in Collections:[China Medical University Hospital] Jurnal articles

    Files in This Item:

    File SizeFormat
    0KbUnknown542View/Open


    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback